Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1–10

Article  PubMed  Google Scholar 

Rosenberg J, Huang J (2018) CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy. Curr Opin Chem Eng 19:9–20

Article  PubMed  Google Scholar 

Huang AC, Orlowski RJ, Xu X et al (2019) A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma. Nat Med 25:454–461. https://doi.org/10.1038/s41591-019-0357-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cursons J, Souza-Fonseca-Guimaraes F, Foroutan M et al (2019) A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients. Cancer Immunol Res 7:1162–1174. https://doi.org/10.1158/2326-6066.CIR-18-0500

Article  CAS  PubMed  Google Scholar 

Vivier E, Tomasello E, Baratin M et al (2008) Functions of natural killer cells. Nat Immunol 9:503–510. https://doi.org/10.1038/ni1582

Article  CAS  PubMed  Google Scholar 

Sottile R, Pangigadde PN, Tan T et al (2016) HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors. Eur J Immunol 46:409–419. https://doi.org/10.1002/eji.201445289

Article  CAS  PubMed  Google Scholar 

Nicolai CJ, Wolf N, Chang I-C et al (2020) NK cells mediate clearance of CD8 + T cell–resistant tumors in response to STING agonists. Sci Immunol 5. https://doi.org/10.1126/sciimmunol.aaz2738

Dustin ML, Long EO (2010) Cytotoxic immunological synapses. Immunol Rev 235:24–34

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez-Lostao L, Anel A, Pardo J (2015) How do cytotoxic lymphocytes kill cancer cells? Clin Cancer Res 21:5047–5056. https://doi.org/10.1158/1078-0432.CCR-15-0685

Article  CAS  PubMed  Google Scholar 

Kearney CJ, Vervoort SJ, Hogg SJ et al (2018) Tumor immune evasion arises through loss of TNF sensitivity. Sci Immunol 3. https://doi.org/10.1126/sciimmunol.aar3451

Chouaib S, Janji B, Tittarelli A et al (2014) Tumor plasticity interferes with anti-tumor immunity. https://doi.org/10.1615/critrevimmunol.2014010183

Xiao Z, Wang R, Wang X et al (2023) Impaired function of dendritic cells within the tumor microenvironment. Front Immunol 14. https://doi.org/10.3389/fimmu.2023.1213629

Pietrobon V, Marincola FM (2021) Hypoxia and the phenomenon of immune exclusion. J Transl Med 19:9. https://doi.org/10.1186/s12967-020-02667-4

Article  PubMed  PubMed Central  Google Scholar 

Barsoum IB, Smallwood CA, Siemens DR, Graham CH (2014) A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74:665–674. https://doi.org/10.1158/0008-5472.CAN-13-0992

Article  CAS  PubMed  Google Scholar 

Melaiu O, Lucarini V, Cifaldi L, Fruci D (2020) Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol 10. https://doi.org/10.3389/fimmu.2019.03038

López-Soto A, Gonzalez S, Smyth MJ, Galluzzi L (2017) Control of metastasis by NK cells. Cancer Cell 32:135–154. https://doi.org/10.1016/j.ccell.2017.06.009

Article  CAS  PubMed  Google Scholar 

Collins PL, Cella M, Porter SI et al (2019) Gene regulatory programs conferring phenotypic identities to human NK cells. Cell 176:348-360.e12. https://doi.org/10.1016/j.cell.2018.11.045

Article  CAS  PubMed  Google Scholar 

Peng H, Tian Z (2017) Diversity of tissue-resident NK cells. Semin Immunol 31:3–10. https://doi.org/10.1016/j.smim.2017.07.006

Article  CAS  PubMed  Google Scholar 

Barry KC, Hsu J, Broz ML et al (2018) A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments. Nat Med 24:1178–1191. https://doi.org/10.1038/s41591-018-0085-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muntasell A, Rojo F, Servitja S et al (2019) NK cell infiltrates and HLA class I expression in primary HER2+ breast cancer predict and uncouple pathological response and disease-free survival. Clin Cancer Res 25:1535–1545. https://doi.org/10.1158/1078-0432.CCR-18-2365

Article  CAS  PubMed  Google Scholar 

Böttcher JP, Bonavita E, Chakravarty P et al (2018) NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172:1022-1037.e14. https://doi.org/10.1016/j.cell.2018.01.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cózar B, Greppi M, Carpentier S et al (2021) Tumor-infiltrating natural killer cells. Cancer Discov 11:34–44

Cantoni C, Wurzer H, Thomas C, Vitale M (2020) Escape of tumor cells from the NK cell cytotoxic activity. J Leukoc Biol 108:1339–1360

Article  CAS  PubMed  Google Scholar 

Bald T, Krummel MF, Smyth MJ, Barry KC (2020) The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies. Nat Immunol 21:835–847

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vivier E, Nunès JA (1979) Vély F (2004) Natural killer cell signaling pathways. Science 306:1517–1519. https://doi.org/10.1126/science.1103478

Article  Google Scholar 

Barrow AD, Martin CJ, Colonna M (2019) The natural cytotoxicity receptors in health and disease. Front Immunol 10. https://doi.org/10.3389/fimmu.2019.00909

Fuertes MB, Domaica CI, Zwirner NW (2021) Leveraging NKG2D ligands in immuno-oncology. Front Immunol 12. https://doi.org/10.3389/fimmu.2021.713158

Bottino C, Castriconi R, Pende D et al (2003) Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198:557–567. https://doi.org/10.1084/jem.20030788

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barber DF, Faure M, Long EO (2004) LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol 173:3653–3659. https://doi.org/10.4049/jimmunol.173.6.3653

Article  CAS  PubMed  Google Scholar 

Alter G, Malenfant JM, Altfeld M (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294:15–22. https://doi.org/10.1016/j.jim.2004.08.008

Article  CAS  PubMed  Google Scholar 

Ramírez-Labrada A, Pesini C, Santiago L et al (2022) All about (NK cell-mediated) death in two acts and an unexpected encore: initiation, execution and activation of adaptive immunity. Front Immunol 13. https://doi.org/10.3389/fimmu.2022.896228

Bryceson YT, March ME, Barber DF et al (2005) Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 202:1001–1012. https://doi.org/10.1084/jem.20051143

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossin A, Miloro G, Hueber A-O (2019) TRAIL and FasL functions in cancer and autoimmune diseases: towards an increasing complexity. Cancers (Basel) 11:639. https://doi.org/10.3390/cancers11050639

Article  CAS  PubMed  Google Scholar 

Prager I, Liesche C, van Ooijen H et al (2019) NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing. J Exp Med 216:2113–2127. https://doi.org/10.1084/jem.20181454

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kearney CJ, Lalaoui N, Freeman AJ et al (2017) PD-L1 and IAPs co-operate to protect tumors from cytotoxic lymphocyte-derived TNF. Cell Death Differ 24:1705–1716. https://doi.org/10.1038/cdd.2017.94

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang R, Jaw JJ, Stutzman NC et al (2011) Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1. J Leukoc Biol 91:299–309.